Patents
Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780)
03/2006
03/28/2006US7019142 Process for preparing naphthyridones and intermediates
03/28/2006US7019024 Pharmaceutical for treatment of neurological and neuropsychiatric disorders
03/28/2006US7019022 such as ((1R)-6-fluoro-8-(methylsulfonyl)-9-{(1S)-1-[4-(trifluoromethyl)phenyl]ethyl}-2,3,4,9-tetrahydro-1H-carbazol-1-yl)acetic acid for treatment of prostaglandin D2 mediated diseases such as rhinitis, asthma and nasal congestion
03/28/2006US7019006 Compounds useful as anti-inflammatory agents
03/28/2006US7019003 Bactericides
03/28/2006US7019000 administering nitrogen-sulfur compounds, e.g. 4,4-dithiodimorpholine to inhibit binding of the E6 protein by human papilloma virus; treatment of cervical cancer
03/28/2006US7018431 Useful as fluorescent labels of nucleosides, nucleotides, polynucleotides, and polypeptides.
03/28/2006CA2147451C 3-indolylpiperidines
03/28/2006CA2120374C 9-[(substituted glycyl) amido]-6-(substituted)-5-hydroxy-6-deoxytetracyclines
03/23/2006WO2006031770A1 Process for the scalable synthesis of 1, 3, 4, 9-tetrahydropyrano[3, 4-b]-indole derivatives
03/23/2006WO2006031179A1 Process for preparation of phtalimide
03/23/2006WO2006030304A2 Novel forms of fluvastatin sodium, processes for preparation and pharmaceutical compositions thereof
03/23/2006WO2006030208A1 Amino acid
03/23/2006WO2006030106A1 3-spiro-indolin-2-one derivatives, preparation and therapeutic use thereof
03/23/2006WO2006030105A1 3-spiro-indolin-2-one derivatives as vasopressin receptor ligand
03/23/2006WO2006029912A1 Indole derivatives as antiviral agents
03/23/2006WO2006029799A1 Iodine-phenyl-substituted cyclic cetoenols
03/23/2006WO2006008133A3 Modulators of alpha7 nicotinic acetylcholine receptors and therapeutic uses thereof
03/23/2006WO2005040102A3 Novel compounds and their use as antidiabetic and hypolipidemic agents, process for their preparation and pharmaceutical compositions containing them
03/23/2006US20060063941 Perindopril
03/23/2006US20060063940 3-(arylamino)methylene-1, 3-dihydro-2H-indol-2-ones as kinase inhibitors
03/23/2006US20060063937 pathogenic form of amyloid beta polypeptides inhibitor; 2-(2-Fluoro-1,1'-biphenyl-4-yl)-2-methylpropanoic acid; nonsteroidal antiinflammatory agent, neuroprotectant, ; side effect reduction; cyclooxygenase inhibitor; Alzheimer's disease, cognition activator, neurogenerative disease
03/23/2006US20060063864 Diindole substituted squarylium compound; filters capable of selectively blocking light with wavelengths that degrade color purity
03/23/2006US20060063823 Inhibitors of 15-lipoxygenase
03/23/2006US20060063807 Low molecular weight peptidomimetic growth hormone secretagogues
03/23/2006US20060063769 Preventives/remedies for urinary disturbance
03/23/2006US20060063762 Indole indazole and benzazole derivative
03/23/2006US20060063760 Hydroxamic acids useful in the treatment of hyper-proliferative disorders
03/23/2006US20060063759 e.g. 5-(10,11-Dihydro-dibenzo[a,d]cyclohepten-5-ylidenemethyl)-3H-benzooxazol-2-one; antiinflammatory, antidiabetic agent; electrolytes and water retention modulator; hypotensive, hypoglycemic agent; arrhythmias, myocardial fibrosis, osteoporosis, polyuria, polydipsia, Crohn's disease
03/23/2006US20060063247 Increased thermostability, photostability, and water solubility
03/23/2006US20060063027 Organic electroluminescent element
03/23/2006DE10297824T5 Verfahren zum Einsatz von Wasserstoff zur reduktiven Acylierung von Nitro-, Azido- und Cyanarenen A method of using hydrogen for the reductive acylation of nitro, azido and cyano arenes
03/23/2006CA2580627A1 Nitrate esters and their use for mitigating cellular damage
03/23/2006CA2580328A1 Iodine-phenyl-substituted cyclic ketoenols
03/23/2006CA2579799A1 Benzoyl-substituted serine amides
03/23/2006CA2578355A1 Methods of treating a disorder
03/23/2006CA2573508A1 Process for the scalable synthesis of 1, 3, 4, 9-tetrahydropyrano[3, 4-b]-indole derivatives
03/23/2006CA2568832A1 Indole derivatives as antiviral agents
03/22/2006EP1637520A1 Polymethine ethers
03/22/2006EP1636185A1 Novel crystalline forms of perindopril erbumine
03/22/2006EP1636184A2 Fluvastatin sodium crystal forms, processes for preparing them, compositions containing them and methods of using them
03/22/2006EP1636182A2 Prodrugs of mitotic kinesin inhibitors
03/22/2006EP1635909A2 Treatment of amyloid- and epileptogenesis-associated diseases
03/22/2006EP1635818A1 Fused indoles as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
03/22/2006EP1635639A1 Use of isoindolinone derivatives as insecticides
03/22/2006EP1480951A4 Synthesis of indole thiazole compounds as ligands for the ah receptor
03/22/2006EP1472221B1 Substituted indoles, method for production and use thereof for the inhibition of pain
03/22/2006EP1309586B1 4-, 5-, 6- and 7-indole derivatives useful for the treatment of cns disorders
03/22/2006EP1250314B1 3-phenoxy-1-phenyl acetylene derivatives and their use as herbicides
03/22/2006EP1140840B1 -g(v)-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
03/22/2006EP1029541B1 Therapeutic or prophylactic agent for glomerulopathy
03/22/2006CN1751101A Metal complexes as light-absorbing compounds in the information layer of optical data carriers
03/22/2006CN1751037A Sulfonamide derivatives as PPAR modulators
03/22/2006CN1751017A Preparation of substituted phthalic anhydride, especially 4-chlorophthalic anhydride
03/22/2006CN1749254A Double spiro material containing heteroaton and its synthetic method and use
03/22/2006CN1245983C Compound for prevention and treatment of neurodegenerative disease
03/22/2006CN1245974C Carvedilol
03/21/2006US7015241 Appetite-stimulating agents and remedies for anorexia
03/21/2006US7015220 enzyme inhibitors used as modulators of tyrosine kinase signal transduction and/or as antiproliferative agents; prophylaxis of vision defects, cancer, atherosclerosis, restenosis, metabolic disorders or autoimmune diseases
03/21/2006US7014981 Benzoindole styryl compounds and their uses in high-density recording media
03/21/2006CA2399358C Pyrrole substituted 2-indolinone protein kinase inhibitors
03/21/2006CA2242416C Sulfonated amino acid derivatives and metalloproteinase inhibitors containing the same
03/21/2006CA2124932C Sex steroid activity inhibitors
03/16/2006WO2006028964A1 Processes for the preparation of substituted 2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolines
03/16/2006WO2006028239A1 Carbamoyl-substituted spiro derivative
03/16/2006WO2006028038A1 Sulfonamide derivative selectively inhibiting mmp-13
03/16/2006WO2006027135A1 4-aminomethyl benzamidine derivatives and their use as factor viiia inhibitors
03/16/2006WO2006005609A3 Substituted oxindol derivatives and medicaments containing the same
03/16/2006US20060058553 Novel bicyclic hydroxamates as inhibitors of histone deacetylase
03/16/2006US20060058532 Process for the scalable synthesis of 1,3,4,9-tetrahydropyrano[3,4-b]-indole derivatives
03/16/2006US20060058370 Methods for producing cyclic benzamidine derivatives
03/16/2006US20060058368 Such as (1-Benzyl-2-hydroxy-3-{isobutyl-[2-oxo-3-(1H-pyrrol-2-ylmethylene)-2,3-dihydro-1H-indole-5-sulfonyl]-amino}-propyl)-carbamic acid hexahydro-furo[2,3-b]furan-3-yl ester; multi-drug resistant HIV infections
03/16/2006US20060058367 Synthesis of amines and intermediates for the synthesis thereof
03/16/2006US20060058362 7-Amido-isoindolyl compounds and methods of their use
03/16/2006US20060058315 2-Oxo-ethanesulfonamide derivates
03/16/2006CA2579204A1 Carbamoyl-substituted spiro derivative
03/16/2006CA2579004A1 Mercaptoamides as histone deacetylase inhibitors
03/16/2006CA2578789A1 Substituted heterocyclic compounds and uses thereof
03/16/2006CA2577608A1 4-aminomethyl benzamidine derivatives and their use as factor viia inhibitors
03/15/2006EP1634883A1 2-substituted phenyl-5,7-dialkyl-3,7-dihydropyrrole[2,3-d]pyrimidine-4-one derivatives, the preparation and the pharmaceutical use thereof
03/15/2006EP1634870A1 Process and intermediates for the selective synthesis of Fluvastatin
03/15/2006EP1634594A1 Use of 3-substituted oxindole derivatives as KCNQ potassium channel modulators
03/15/2006EP1633739A1 Process for the preparation of anhydrous eleptritan hemisulphate
03/15/2006EP1633716A2 Biarylmethyl indolines, indoles and tetrahydroquinolines, useful as serine protease inhibitors
03/15/2006EP1633711A1 Process and intermediates for the preparation of (1r,2s,5s)-6,6-dimethyl-3-azabicyclo [3,1,0] hexane-2-carboxylates or salts thereof
03/15/2006EP1633710A1 Isoindolin-1-one compounds as kinase inhibitors
03/15/2006EP1633709A1 Anti-diabetic agents
03/15/2006EP1633704A2 Intermediates useful in the synthesis of hiv-protease inhibitors and methods for preparing the same
03/15/2006EP1633702A1 Protease inhibitors
03/15/2006EP1633694A2 Substituted indoles and a process for preparing substituted indoles
03/15/2006EP1633692A2 Cyclohexyl derivatives as selective estrogen receptor modulators
03/15/2006EP1408962B1 Substituted isoindoles and the use thereof
03/15/2006CN1748017A Carbazole compounds and use of such compounds in organic electroluminescent devices
03/15/2006CN1747948A Novel n-monoacylated o-phenylenediamines, their condensed heterocyclic derivatives and their use as pharmaceutical agents
03/15/2006CN1746160A Synthesis of plant growth hormone 3-indolebutyric acid
03/15/2006CN1746159A Indole separation and purification
03/15/2006CN1746158A Salted extract separation of indole
03/15/2006CN1746157A Refining method of indoly dissoluable and separated crystallation
03/15/2006CN1245394C Substituted phenylacetamides and their use as glucokinase activators
03/15/2006CN1245385C Indole and dihydroindole derivatives